NextPlat's biggest risks in the FY2024 10-K
- NextPlat relies heavily on Amazon and Alibaba marketplaces, generating 32.8% of 2024 sales on Amazon and 67% internationally.
- The company faces ongoing net losses, posting a $23.1 million net loss in 2024 and an accumulated deficit of $49.0 million.
- Operations span diverse sectors including pharmacy services, e-commerce, and satellite tracking device development.
The risks most specific to NextPlat
- Risks Related to Our Business
We have a history of net losses, and we are uncertain about our future profitability
We incurred net losses of approximately $23.1 million and $12.4 million for the years ended December 31, 2024 and 2023, respectively, with an accumulated deficit of approximately $49.0 million.
- Risks Related to Our e-Commerce Business
Our sales may be impacted should there be a disruption of service to our Amazon or Alibaba online storefronts
Our Amazon online marketplaces represented approximately 32.8% and 51.6% of total sales for the years ended December 31, 2024 and 2023, respectively, and we also sell through Alibaba.
- Risks Related to Our Business
Our operations in international markets, and earnings in those markets, may be affected by changes in global cultural, political, and financial market conditions as well as potential changes in regulations, legislation and government policies such as tariffs, tax laws and global trade policies
Approximately 67% of our sales for the year ended December 31, 2024 were earned in international markets, exposing us to foreign regulations, tariffs, and tax laws.
- Risks Related to Our Business
We may need to raise additional capital to grow our business and satisfy our anticipated future liquidity needs, and we may not be able to raise it on terms acceptable to us, or at all
As of December 31, 2024, we had cash on hand of approximately $20.0 million, and we may need to raise additional capital on acceptable terms to fund our growth.
- Risks Related to Our Business
Product development is a long, expensive and uncertain process
The development of our own branded range of satellite tracking devices is a costly, complex, and time-consuming process with an uncertain return on investment.
- Risks Related to Our Business
Concentration of ownership by our principal stockholders may result in control by such stockholders of the composition of our board of directors
Our existing principal stockholders, named executive officers, and directors beneficially own approximately 39.7% of our outstanding common stock as of March 17, 2025.
- Risks Related to Our e-Commerce Business
Our current plans contemplate that we will expand our online marketing presence primarily via the Alibaba ecosystem. Any termination or material change in our relationship with Amazon or Alibaba could have a material adverse effect on our business, financial condition, results of operations and prospects
Our current plans contemplate expanding our online marketing presence primarily via the Alibaba ecosystem, and any termination of our Amazon or Alibaba relationship would harm us.
All 113 risk factors
Headings as the filing states them, in filing order.
Other
- 01Unexpected safety or efficacy concerns may arise from pharmaceutical products
- 02Efforts to reform the U.S. health care system may adversely affect our financial performance
- 03Product liability, product recall or personal injury issues could damage our reputation and have a significant adverse effect on our businesses, operating results, cash flows and/or financial condition
Risks Related to the Pharmacy Industry
- 04If demand for our products and services is reduced, our business and ability to grow would be harmed
- 94There is substantial competition in our industry, and we may not be able to compete successfully
- 95Many specialty patients are currently receiving prescription benefits from federally funded programs such as the Ryan White CARE Act. These payors only use non-profit providers to dispense medications to their enrollees
- 96Our revenues could be adversely affected if new drugs or combination therapies are developed and prescribed to our patients that have a reimbursement rate less than that of the current drug therapies our patients receive
- 97If our credit terms with vendors become unfavorable or our relationship with them is terminated, our business could be adversely affected
Risks Relating to Our Data Management Services
- 05Competition with some customers, or decisions by customers to perform internally some of the same solutions or services that we offer, could harm our business, results of operations or financial condition
- 06Our ability to generate revenue could suffer if we do not continue to update and improve existing solutions and develop new ones
- 07Breaches and failures of our IT systems and the security measures protecting them, and the sensitive information we transmit, use and store, expose us to potential liability and reputational harm
- 08If we are unable to successfully execute on cross-selling opportunities of our solutions the growth of our business and financial performance could be harmed
- 98Competition with some customers, or decisions by customers to perform internally some of the same solutions or services that we offer, could harm our business, results of operations or financial condition
- 99If our solutions do not interoperate with our customers’ or their vendors’ networks and infrastructures, or if customers or their vendors implement new system updates that are incompatible with our solutions, sales of those solutions could be adversely affected
- 100Our business relies on sophisticated information systems to obtain, rapidly process, analyze, and manage data, affecting our ability to provide services. To the extent our IT systems are not successfully implemented or fail, our business and results of operations may be adversely affected
- 101We collect, process, store, share, disclose and use personal information and other data, and our actual or perceived failure to protect such information and data could damage our reputation and brand and harm our business and operating results
- 102Federal and state privacy and security regulations may increase our cost of operations and expose us to civil and criminal sanctions, damages, and penalties
- 103other potential interruptions
Risks Related to Our Business
- 09We have a history of net losses, and we are uncertain about our future profitability
- 10Events outside of our control, including those relating to public health crises, supply-chain disruptions, geopolitical conflicts, including acts of war, and inflation, could negatively affect our Company and our results of operations and financial condition
- 11Supply chain and shipping disruptions have resulted in shipping delays, a significant increase in shipping costs, and could increase product costs and result in lost sales, which may have a material adverse effect on our business, operating results and financial condition
- 12Our dependence on key suppliers puts us at risk of interruptions in the availability of our products, which could reduce our revenue and adversely affect the results of operations. In addition, increases in prices for components used in our products could adversely affect our results of operations
- 13Unfavorable global economic conditions have in the past and could in the future adversely affect our business, financial condition or results of operations
- 14Continued inflation and increases in labor costs may reduce our profitability
- 15Government efforts to combat inflation, along with other interest rate pressures arising from an inflationary economic environment, could lead to us to incur even higher interest rates and financing costs and may reduce our profitability
- 16Currency exchange rate fluctuations may affect the results of operations
- 17We may need to raise additional capital to grow our business and satisfy our anticipated future liquidity needs, and we may not be able to raise it on terms acceptable to us, or at all
- 18Sustained investment in our business, strategic acquisitions and investments, as well as our focus on long-term performance, and on maintaining the health of our new e-commerce ecosystem, may negatively affect our margins and our net income, if any
- 19Although we believe these investments are crucial to our viability and future growth, they will have the effect of increasing our costs and lowering our margins and profit, and this effect may be significant in the short term and potentially over longer periods
- 20Failure to maintain or improve our technological infrastructure could harm our business and prospects
- 21Product development is a long, expensive and uncertain process
- 22Concentration of ownership by our principal stockholders may result in control by such stockholders of the composition of our board of directors
- 23Successful technical development of our products does not guarantee successful commercialization
- 24demonstrations of the products not aligning with or meeting customer needs
- 25Public company compliance may make it more difficult to attract and retain officers and directors
- 26Conflicts of interest may arise between us and our directors and officers as a result of other business activities undertaken by such individuals
- 27Other companies may claim that we infringe their intellectual property, which could materially increase our costs and harm our ability to generate future revenue and profit
- 28We may not be able to protect our intellectual property rights
- 29Being a public company is expensive and administratively burdensome
- 30involve, to a greater degree, our outside legal counsel and accountants in the above activities
- 31We may fail to maintain effective internal control over financial reporting and effective disclosure controls and procedures, and as a result, we may not be able to accurately report our financial results in a timely manner or prevent fraud, which may adversely affect investor confidence in our company
- 32We will become subject to a broad range of laws and regulations, and future laws and regulations may impose additional requirements and other obligations that could materially and adversely affect our business, financial condition and results of operations, as well as the trading prices of our securities
- 33complying with applicable laws, rules and regulations relating to the collection (from users and other third-party systems or sources), use, storage, transfer, disclosure and security of personal data, including requests from data subjects and regulatory and government authorities
- 34The nature of our business involves significant risks and uncertainties that may not be covered by insurance or indemnity
- 35Designing and developing products to collect, distribute and analyze various types of information
- 36Our operations in international markets, and earnings in those markets, may be affected by changes in global cultural, political, and financial market conditions as well as potential changes in regulations, legislation and government policies such as tariffs, tax laws and global trade policies
Risks Related to Our e-Commerce Business
- 37Our sales may be impacted should there be a disruption of service to our Amazon or Alibaba online storefronts
- 38Creating and maintaining a trusted status of our online marketing presence or ecosystem will be critical to our viability and growth, and any failure to do so could severely damage our reputation, which would have a material adverse effect on our business, financial condition, results of operations and prospects
- 39Our current plans contemplate that we will expand our online marketing presence primarily via the Alibaba ecosystem. Any termination or material change in our relationship with Amazon or Alibaba could have a material adverse effect on our business, financial condition, results of operations and prospects
- 40We may not be able to maintain or grow our revenue or our business
- 41If we are unable to compete effectively, our business, financial condition and results of operations would be materially and adversely affected
- 42In addition, the development of new technologies and satellite systems, including Low Earth Orbit (LEO) constellations designed to deliver global satellite internet and support voice and data calls via mobile phones, may reduce the competitiveness of some of our products or render them obsolete in the future
- 43We may not be able to maintain and improve our online marketing, which could negatively affect our business and prospects
- 44continue adapting to the changing demands of the market
- 45If we are not able to continue to innovate or if we fail to adapt to changes in our various industries, our business, financial condition and results of operations would be materially and adversely affected
- 46Our failure to manage the significant management, operational and financial challenges involved in growing our business and operations could harm us
- 47We face risks relating to our acquisitions, investments and alliances
- 48difficulties in conducting sufficient and effective due diligence on potential targets and unforeseen or hidden liabilities or additional incidences of non-compliance, operating losses, costs and expenses that may adversely affect us following our acquisitions or investments or other strategic transactions
- 49We face challenges in expanding our international and cross-border businesses and operations
- 50We are heavily reliant on Charles Fernandez, our Executive Chairman and Chief Executive Officer, and the departure or loss of Mr. Fernandez could disrupt our business
- 51We are heavily reliant on David Phipps, our President and Chief Executive Officer of Global Operations and a director, and the departure or loss of David Phipps could disrupt our business
- 52If we are unable to recruit and retain key management, technical and sales personnel, our business would be negatively affected
- 53We depend on key management as well as experienced and capable personnel generally, and any failure to attract, motivate and retain our staff could severely hinder our ability to maintain and grow our business
- 54Failure to deal effectively with fraudulent or illegal activities by our employees, business partners or service providers would harm our business
- 55If the logistics service providers used by our merchants fail to provide reliable logistics services, our business and prospects, as well as our financial condition and results of operations, may be materially and adversely affected
- 56Failure to deal effectively with any fraud perpetrated and fictitious transactions conducted in our ecosystem, and other sources of customer dissatisfaction, would harm our business
- 57Our e-commerce platforms depend on the efficient and uninterrupted operation of our computer and communications systems. System interruptions and delays may prevent us from efficiently processing the large volume of transactions on our marketplaces and other businesses we operate
- 58Natural disasters, terrorist acts or acts of war may cause equipment failures or disrupt our systems and operations. A failure to protect the privacy of customer and employee confidential data against breaches of network or IT security could result in damage to our reputation
- 59Non-compliance with, or changes in, the legal and regulatory environment in the countries in which we operate could increase our costs or reduce our net operating revenues
- 60Tightening of tax compliance efforts that affect our merchants could materially and adversely affect our business, financial condition and results of operations
- 61We may be subject to claims under consumer protection laws, including health and safety claims and product liability claims, if property or people are harmed by the products and services sold through our platforms
- 62We may also face increasing scrutiny from consumer protection regulators and activists, as well as increasingly become a target for litigation, in the United States, Europe and other jurisdictions
- 63Our business activities may be subject to the Foreign Corrupt Practices Act (“FCPA”), the UK Bribery Act 2010 (“UK Bribery Act”), and other similar anti-bribery and anti-corruption laws of other countries in which we operate
- 64Our reputation, our brand and our business may be harmed by aggressive marketing and communications strategies of our competitors
Risks Related to Doing Business in China
- 65Our current business expansion involves an increase in the business we do in China. Changes in China’s economic, political or social conditions or government policies could have a material adverse effect on our business, financial conditions and results of operations
- 66We currently market our products and services in China, and may establish operations in China at a future time, all of which may expose our business, prospects, financial condition and results of operations to an increasingly significant extent to political, economic, and social conditions in China generally
- 67Uncertainties with respect to the PRC legal system could adversely affect us
- 68Recent litigation and negative publicity surrounding China-based companies listed in the United States may negatively impact the trading price of our securities
- 69Fluctuations in exchange rates could have a material and adverse effect on the results of our operations and the value of your investment
- 70Governmental control of currency conversion may limit our ability to utilize our revenues effectively and affect the value of your investment
Risks Related to Our Healthcare Business
- 71We derive a significant portion of our sales from prescription drug sales reimbursed by pharmacy benefit management companies
- 72Efforts to reduce reimbursement levels and alter health care financing practices could adversely affect our businesses
- 73A slowdown in the frequency and rate of the introduction of new prescription drugs as well as generic alternatives to brand name prescription products could adversely affect our business, financial position, and results of operations
- 74Uncertainty regarding the impact of Medicare Part D may adversely affect our business, financial position and our results of operations
- 75Prescription volumes may decline, and our net revenues and ability to generate earnings may be negatively impacted, if products are withdrawn from the market or if increased safety risk profiles of specific drugs result in utilization decreases
- 76Certain risks are inherent in providing pharmacy services; our insurance may not be adequate to cover any claims against us
- 77Contracts in the prescription drug industry generally use certain published benchmarks to establish pricing for prescription drugs. These benchmarks include average wholesale price (“AWP”), average sales price and wholesale acquisition cost
- 78Increases in our pharmaceutical costs could have a material adverse effect on the level of our medical costs and our results of operations
- 79The industries in which we operate are extremely competitive and competition could adversely affect our business, financial position, and results of operations
- 80Existing and new government legislative and regulatory action could adversely affect our business, financial position and results of operations
- 81Future rulemaking could increase regulation of pharmacy services, result in changes to pharmacy reimbursement rates, and otherwise change the way we do business. We cannot predict the timing or impact of any future rulemaking, but any such rulemaking could have an adverse impact on our results of operations
- 82If we are found to be in violation of Medicaid and Medicare reimbursement regulations, we could become subject to retroactive adjustments and recoupment, or exclusion from the Medicaid, Medicare programs, and PBM networks
- 83Our industry is subject to extensive government regulation, and noncompliance by us or our suppliers could harm our business
- 84If the products and services that we offer fail to meet customer needs, our sales may be affected
- 85We are highly dependent on one supplier for our products, and a loss of that supplier may adversely impact our ability to sell products to our customers
- 86We derive a significant portion of our revenues from a small number of customers and a loss of one or both of those customers would have a material adverse impact on our business
- 87Our ability to grow our business may be constrained by our inability to find suitable new pharmacy locations at acceptable prices
- 88If we are not able to market our services effectively to clinics, their affiliated healthcare providers and prescription drug providers, we may not be able to grow our patient base as rapidly as we have anticipated
- 89If we fail to manage our growth or implement changes to our reporting systems effectively, our business could be harmed
- 90We may acquire other companies or technologies, which could divert our management’s attention, result in additional dilution to our shareholders and otherwise disrupt our operations and harm our operating results
- 91litigation or other claims in connection with the acquired company, including claims from terminated employees, consumers, former shareholders or other third parties
- 92A disruption in our telephone system or our computer system could harm our business
- 93Our success is highly dependent on the performance of our management team and certain employees, and our continuing ability to attract, develop, motivate, and retain highly qualified and skilled employees and consultants
Risks Related to Our Securities
- 104You may experience dilution of your ownership interests because of the future issuance of additional shares of our common or preferred stock or other securities that are convertible into or exercisable for our common or preferred stock
- 105You will experience future dilution because of future equity offerings
- 106We do not anticipate paying dividends on our common stock, and investors may lose the entire amount of their investment
- 107The ability of our Board of Directors to issue additional stock may prevent or make certain transactions more difficult, including a sale or merger of the Company
- 108Our common stock and warrants are thinly traded and there can be no assurance that a more active public market will ever develop. Failure to develop or maintain an active trading market could negatively affect the value of our common stock and make it difficult or impossible for you to sell your shares
- 109The provisions of our Nasdaq listed Warrants could discourage the acquisition of us by a third party
- 110There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq, a failure of which could result in a de-listing of our common stock
- 111Our stock price may be volatile
- 112economic and other external factors
- 113Offers or availability for sale of a substantial number of shares of our common stock may cause the price of our common stock to decline
Other NextPlat 10-Ks
- FY2025 10-K risk factors30 risks30 new113 dropped
NextPlat faces significant ongoing net losses and reliance on a single pharmaceutical supplier for 98% of purchases. The company struggles with Nasdaq listing compliance, prompting plans for a reverse stock split. Macroeconomic pressures and inflation continue to threaten profit margins and operating costs.
Filed Mar 31, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.